Notable Labs Ltd. is a clinical-stage platform therapeutics company that develops predictive medicines for patients with cancer. Through its proprietary Predictive Medicines Platform, the firm predicts whether or not that patient is likely to respond to that specific therapeutic. The company's Predictive Medicines Platform is designed to identify and select patients expected to be clinically responsive prior to their treatment to improve patient outcomes and fast-track clinical development. The firm's product candidate, Volasertib, is a Polo-like Kinase 1 inhibitor. Notable Labs was founded on January 31, 2000 and is headquartered in Foster City, CA.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Vascular Biogenics Ltd?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Vascular Biogenics Ltd market cap is $2.39M.
What is the 52-week high for Vascular Biogenics Ltd?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Vascular Biogenics Ltd 52 week high is $0.6658 as of September 10, 2025.
What is the 52-week low for Vascular Biogenics Ltd?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Vascular Biogenics Ltd 52 week low is $0.22 as of September 10, 2025.
What is Vascular Biogenics Ltd stock price today?
Vascular Biogenics Ltd stock price today is $0.2479.
What was Vascular Biogenics Ltd stock price yesterday?
Vascular Biogenics Ltd stock price yesterday was $0.3428.
What is the PE ratio of Vascular Biogenics Ltd?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Vascular Biogenics Ltd’s P/E ratio is -0.03.
What is the Price-to-Book ratio of Vascular Biogenics Ltd?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Vascular Biogenics Ltd P/B ratio is 0.3332.
What is the 50-day moving average of Vascular Biogenics Ltd?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Vascular Biogenics Ltd 50-day moving average is $0.2479.
